Dynorphin--still an extraordinarily potent opioid peptide
about
Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on AddictionSalvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disordersKappa Opioids, Salvinorin A and Major Depressive DisorderEndogenous Opioids: The Downside of Opposing Stress.Endogenous opioids: opposing stress with a cost.Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic PerspectiveUpregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment.Nicotine Increases Alcohol Intake in Adolescent Male RatsNeuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Regulation of gene transcription in bipolar disorders: Role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor.Structure-Activity Relationships of [des-Arg7]Dynorphin A Analogues at the κ Opioid Receptor.Contrasting Regulation of Catecholamine Neurotransmission in the Behaving Brain: Pharmacological Insights from an Electrochemical Perspective.Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.An indirect resilience to addiction.Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction.Altered secondary structure of Dynorphin A associates with loss of opioid signalling and NMDA-mediated excitotoxicity in SCA23.Prodynorphin and kappa opioid receptor mRNA expression in the brain relates to social status and behavior in male European starlings.Intra- and interregional coregulation of opioid genes: broken symmetry in spinal circuits.Neuronal Expression of Opioid Gene is Controlled by Dual Epigenetic and Transcriptional Mechanism in Human Brain.N,N-dimethyltryptamine and the pineal gland: Separating fact from myth.Preprodynorphin-expressing neurons constitute a large subgroup of somatostatin-expressing GABAergic interneurons in the mouse neocortex.
P2860
Q26770785-A35D1ECA-5CE3-4C51-ADCE-A06C04046DDCQ26781580-8B11A44B-13AF-4AB4-84CD-11A343C99F65Q28075656-55315828-EDD4-4A40-890A-ADEE030BB60EQ30394985-22DBA59A-D9F2-450A-9AD5-BB6546464B8CQ30408911-FED43B20-99F6-4E3F-833E-04D373D1E37AQ36305030-3932199A-7E9F-4CB0-B2F6-7614D9DC735AQ36363810-6BB5BAC7-D440-468F-A263-315B74D2556FQ36992406-9A82ED5C-5227-48CB-9CC0-35394A7DD922Q37281169-8D35F09D-2E56-4548-B075-CC464B468BE6Q37656941-1D7B2A94-8C0B-490E-A68D-81DECD180E26Q38217456-AC39EE30-6735-4F94-9E7B-8F31D898C220Q38613470-62F9352B-2233-4068-903F-0A8272BF07ADQ38734980-79E9B35B-1F8B-4961-9C42-D8848416836EQ39166257-DD60EF38-6413-4495-8C0E-6AEC24D3FE19Q39251520-7522E2D2-B4BB-436B-B0FC-1282A76D53BFQ39301236-4BBDB448-01DC-4037-8987-E523191B2455Q40742576-5802975C-1371-4DEA-B1CA-F756037A2A7BQ42123305-3997E43E-7BF5-4D5F-AB20-F754E13E9703Q44337739-AF80F930-A989-48E0-89BC-02D51267B0EDQ44341733-3B8BB383-42F9-4B99-838F-6048E2D0C121Q44342902-1AAD38C5-02F4-4D11-B017-3FAF9434ACA6Q44349402-21BC1250-03C9-4AEF-9A58-7C9F3CAB1D61Q46782566-FBB0DA8B-C70F-47B8-9846-E26242DAE8D8Q48934804-A79B0153-6A02-4E14-818B-E7BE07AAA7EF
P2860
Dynorphin--still an extraordinarily potent opioid peptide
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Dynorphin--still an extraordinarily potent opioid peptide
@ast
Dynorphin--still an extraordinarily potent opioid peptide
@en
Dynorphin--still an extraordinarily potent opioid peptide
@nl
type
label
Dynorphin--still an extraordinarily potent opioid peptide
@ast
Dynorphin--still an extraordinarily potent opioid peptide
@en
Dynorphin--still an extraordinarily potent opioid peptide
@nl
prefLabel
Dynorphin--still an extraordinarily potent opioid peptide
@ast
Dynorphin--still an extraordinarily potent opioid peptide
@en
Dynorphin--still an extraordinarily potent opioid peptide
@nl
P2860
P356
P1476
Dynorphin--still an extraordinarily potent opioid peptide
@en
P2093
C. Chavkin
P2860
P304
P356
10.1124/MOL.112.083337
P407
P577
2013-04-01T00:00:00Z